The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems ...

Researchers found that COVID-19 mRNA vaccines, when given within 100 days of starting immune checkpoint inhibitors, were ...

Company to discontinue development of mRNA-1647 in congenital CMV Company will continue to evaluate mRNA-1647 in ongoing Phase 2 trial in bone marrow transplant patients Company does not anticipate ...

"People are literally going to die from it," warns researcher who has tracked the anti-vaccine movement for decades.

University of Florida researchers found that advanced lung and skin cancer patients lived “significantly longer” after ...

Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked as a top employer in the global biopharmaceutical industry in Science and Science Careers' 2025 Top Employers Survey for the eleventh ...

A new study finds that combining the COVID vaccine with immunotherapy may nearly double cancer survival rates — patients ...

COVID-19 vaccines were game changing during the course of the pandemic; now another benefit is emerging—the same vaccines are ...

Small study looks only at a cardiac biomarker; findings are in line with reduced myocarditis risk in mRNA COVID vaccines ...

Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event - Analyst Day at 9:00 a.m. ET on Thursday, November 20, 2025.

OPINION: The U.S. once led the charge in confronting the planet's most pressing challenges. But today, that leadership is ...

Retsef Levi may not be a household name, but he is already impacting how every household in the United States will access ...